Navigation Links
Merck Animal Health announces Vetsulin
Date:4/29/2013

SUMMIT, NJApril 29, 2013 Merck Animal Health today announced that Vetsulin (porcine insulin zinc suspension), the only FDA-approved insulin for use in both dogs and cats is now available to veterinarians throughout the United States. The prevalence of diabetes mellitus in dogs and cats ranges from one in 1001 to one in 500, 2 and the number of dogs diagnosed with the disease has tripled during the past 30 years.3 Today, along with proper diet and exercise, Vetsulin plays an important role in successfully managing diabetes in both dogs and cats.

"We are pleased that Vetsulin is again available in the U.S. market; offering our customers the same product benefits that veterinarians worldwide have relied on for the past 20 years," said Christopher Pappas, D.V.M., Director, Technical Services, Merck Animal Health. "At Merck Animal Health, we are committed to providing our full support to veterinarians as they manage the health of dogs and cats living with diabetes."

While only 50 percent of dogs used to survive the first 60 days following a diagnosis of diabetes mellitus, today, dogs receiving the proper treatment have the same expected lifespan as a non-diabetic dog of the same age and gender. 3 With effective treatment, lifestyle changes and monitoring, a diabetic cat also can have the same expected life span as a non-diabetic cat of the same age.

Getting the disease under control is paramount to survival. In a study of dogs treated with Vetsulin, adequate glycemic control was achieved in an average of 81 percent of dogs, 4 and in a pivotal U.S. study of diabetic cats, Vetsulin reduced all major diabetes indicators to within normal range by day 60 of treatment.5,6

Merck Animal Health is committed to supporting veterinarians in the ongoing treatment of their patients, including making diabetes professionals available to answer questions. An in-depth website (http://www.vetsulin.com) provides tools for both veterinarians and pet owners to make monitoring blood glucose levels easier. A wide variety of pet owner educational materials also can be found on the website, including downloadable guides from step-by-step instructions for giving an insulin injection to a management monitoring sheet to keep track of a pet's progress.

Vetsulin should not be used in dogs or cats known to have a systemic allergy to pork or pork products. Vetsulin is contraindicated during periods of hypoglycemia. Keep out of reach of children. As with all insulin products, careful patient monitoring for hypoglycemia and hyperglycemia is essential to attain and maintain adequate glycemic control and prevent associated complications. Overdosage can result in profound hypoglycemia and death. The safety and effectiveness of Vetsulin in puppies and kittens, breeding, pregnant, and lactating dogs and cats has not been evaluated. See package insert for full information regarding contraindications, warnings, and precautions.


'/>"/>

Contact: Kelly Goss, Media Relations
913-422-6846
kelly.goss@merck.com

Contact: Carol Ferguson, Investor Relations
908-423-4465
carol.ferguson@merck.com
Merck
Source:Eurekalert


Related biology news :

1. Rescue me: New study finds animals do recover from neglect
2. Large animal models of Huntingtons disease offer new and promising research options
3. New test for skin sensitization without using animals
4. Sequencing tracks animal-to-human transmission of bacterial pathogens
5. Biodiversity does not reduce transmission of disease from animals to humans
6. Discovery may explain how prion diseases spread between different types of animals
7. July meeting presents animal and dairy science
8. IU discovery on animal memory opens doors to research on memory impairment diseases
9. Animal model of human evolution indicates thick hair mutation emerged 30,000 years ago
10. Scientists discover how animals taste, and avoid, high salt concentrations
11. Bisphenol A affects sex-specific reproductive behaviors in a monogamous animal species
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/29/2020)... ... January 29, 2020 , ... INDIGO Biosciences, Inc. (INDIGO), the ... announced a record earnings year for 2019. With final numbers to be released ... percent increase in revenue and a thirty percent increase in gross profit, and ...
(Date:1/28/2020)... ... January 28, 2020 , ... Blue Health Intelligence (BHI) ... cost of care, and limit the utilization of high-cost imaging and surgeries for ... San Antonio, Texas specializes in improving care delivery for MSK conditions. In an ...
(Date:1/24/2020)... ... 24, 2020 , ... Shoreline Biome , a microbiome research company that ... the company will debut a novel new DNA isolation kit at the Miami ... Biome's Rapid Prep kit, is a fast and easy-to-use kit designed for the efficient ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... ... February 18, 2020 , ... Shoreline Biome, ... the strain level, recently unveiled a novel DNA isolation product. , Shoreline Rapid ... of high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40 kB ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... pleased to announce the successful results from a long-term follow-up clinical study ... Inspan interspinous fixation device (INSPAN LLC). Unlike extension block design, the Inspan ...
(Date:2/5/2020)... (PRWEB) , ... February 05, 2020 , ... Rare ... observance, sponsored by The National Organization for Rare Disorders (NORD), to raise awareness amongst ... ( rarediseaseday.org ). The Balancing Act’s “Behind The Mystery” rare disease series ...
(Date:1/28/2020)... ... January 28, 2020 , ... Genedata, ... the release of Genedata Expressionist ® 13.5 at the 2020 WCBP ... Methods (MAM) for characterizing and monitoring the quality of biopharmaceuticals throughout their ...
Breaking Biology Technology: